CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature

[1]  John L. Johnson,et al.  Effects of BCG vaccination on donor unrestricted T cells in humans , 2021, bioRxiv.

[2]  S. Raychaudhuri,et al.  Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment, and disease , 2021, Nature Immunology.

[3]  Julie G. Burel,et al.  Classical CD4 T cells as the cornerstone of antimycobacterial immunity , 2021, Immunological reviews.

[4]  L. Cowell,et al.  TCRMatch: Predicting T-Cell Receptor Specificity Based on Sequence Similarity to Previously Characterized Receptors , 2020, bioRxiv.

[5]  Julie G. Burel,et al.  Quantitative and Qualitative Perturbations of CD8+ MAITs in Healthy Mycobacterium tuberculosis–Infected Individuals , 2020, ImmunoHorizons.

[6]  J. Kublin,et al.  A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa , 2020, EClinicalMedicine.

[7]  M. Wadsworth,et al.  Prevention of tuberculosis in macaques after intravenous BCG immunization , 2020, Nature.

[8]  K. Stuart,et al.  BCG revaccination boosts adaptive polyfunctional Th1/Th17 and innate effectors in IGRA+ and IGRA- Indian adults. , 2019, JCI insight.

[9]  Julie G. Burel,et al.  Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis , 2019, Front. Immunol..

[10]  T. Ottenhoff,et al.  Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques , 2019, Nature Medicine.

[11]  H. McShane,et al.  Current approaches toward identifying a correlate of immune protection from tuberculosis , 2018, Expert review of vaccines.

[12]  J. Greenbaum,et al.  Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression , 2018, Cell.

[13]  M. Hatherill,et al.  A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates , 2018, bioRxiv.

[14]  H. Fletcher.  Systems approaches to correlates of protection and progression to TB disease. , 2018, Seminars in immunology.

[15]  Robert M. DiFazio,et al.  Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques , 2018, bioRxiv.

[16]  S. Self,et al.  Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents , 2018, The New England Journal of Medicine.

[17]  Julie G. Burel,et al.  Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis , 2018, The Journal of Immunology.

[18]  S. Kaufmann,et al.  Next-Generation Vaccines Based on Bacille Calmette–Guérin , 2018, Frontiers in Immunology.

[19]  Mihaela M. Martis,et al.  Anti-mycobacterial activity correlates with altered DNA methylation pattern in immune cells from BCG-vaccinated subjects , 2017, Scientific Reports.

[20]  S. Kaufmann,et al.  The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing , 2017, Front. Immunol..

[21]  V. Brusic,et al.  PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4+ T cell transcriptomal molecular signatures , 2017, Mucosal Immunology.

[22]  Alessandro Sette,et al.  Identifying specificity groups in the T cell receptor repertoire , 2017, Nature.

[23]  S. Mallal,et al.  T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.

[24]  Julie G. Burel,et al.  An Integrated Workflow To Assess Technical and Biological Variability of Cell Population Frequencies in Human Peripheral Blood by Flow Cytometry , 2017, The Journal of Immunology.

[25]  Dario Ghersi,et al.  Broad TCR Repertoire And Diverse Structural Solutions To Recognition Of An Immunodominant CD8 T Cell Epitope , 2017, Nature Structural &Molecular Biology.

[26]  S. Mallal,et al.  Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses , 2017, PloS one.

[27]  H. Dockrell,et al.  Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants. , 2016, Vaccine.

[28]  H. McShane,et al.  In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy. , 2016, Vaccine.

[29]  Bjoern Peters,et al.  A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans , 2016, PLoS pathogens.

[30]  Dominique N. Price,et al.  Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis , 2016, PLoS pathogens.

[31]  M. Tameris,et al.  T-cell activation is an immune correlate of risk in BCG vaccinated infants , 2016, Nature Communications.

[32]  C. Marsit,et al.  Reference-free deconvolution of DNA methylation data and mediation by cell composition effects , 2016, bioRxiv.

[33]  P. Marsh,et al.  Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques , 2015, Clinical and Vaccine Immunology.

[34]  H. McShane,et al.  Aerosol immunisation for TB: matching route of vaccination to route of infection , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[35]  J. Greenbaum,et al.  Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes , 2014, Proceedings of the National Academy of Sciences.

[36]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[37]  Bjoern Peters,et al.  Transcriptional Profile of Tuberculosis Antigen–Specific T Cells Reveals Novel Multifunctional Features , 2014, The Journal of Immunology.

[38]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[39]  Á. Cruz,et al.  Causes of variation in BCG vaccine efficacy: examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses. , 2014, Vaccine.

[40]  M. Salfinger,et al.  Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification. , 2014, Clinics in laboratory medicine.

[41]  D. Sinderen,et al.  T-cell activation by transitory neo-antigens derived from distinct microbial pathways , 2014, Nature.

[42]  D. Barber,et al.  Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma–Homing CD4 T Cells , 2014, The Journal of Immunology.

[43]  Andrew E. Teschendorff,et al.  ChAMP: 450k Chip Analysis Methylation Pipeline , 2014, Bioinform..

[44]  D. Barber,et al.  Intravascular staining for discrimination of vascular and tissue leukocytes , 2014, Nature Protocols.

[45]  F. Sallusto,et al.  The who's who of T‐cell differentiation: Human memory T‐cell subsets , 2013, European journal of immunology.

[46]  J. Ernst,et al.  Cutting Edge: Direct Recognition of Infected Cells by CD4 T Cells Is Required for Control of Intracellular Mycobacterium tuberculosis In Vivo , 2013, The Journal of Immunology.

[47]  Bjoern Peters,et al.  Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset , 2013, PLoS pathogens.

[48]  R. Xavier,et al.  Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes , 2012, Proceedings of the National Academy of Sciences.

[49]  F. Abebe.  Is interferon‐gamma the right marker for bacille Calmette–Guérin‐induced immune protection? The missing link in our understanding of tuberculosis immunology , 2012, Clinical and experimental immunology.

[50]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[51]  L. Hessel,et al.  Rational approach to selection and clinical development of TB vaccine candidates. , 2012, Tuberculosis.

[52]  Leland Wilkinson,et al.  Exact and Approximate Area-Proportional Circular Venn and Euler Diagrams , 2012, IEEE Transactions on Visualization and Computer Graphics.

[53]  Xinchun Chen,et al.  Multifunctional CD4 T Cell Responses in Patients with Active Tuberculosis , 2012, Scientific Reports.

[54]  M. Tameris,et al.  Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants. , 2011, The Journal of infectious diseases.

[55]  Bjoern Peters,et al.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.

[56]  Gaël Varoquaux,et al.  The NumPy Array: A Structure for Efficient Numerical Computation , 2011, Computing in Science & Engineering.

[57]  Robert A. Edwards,et al.  Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..

[58]  G. Kaplan,et al.  Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. , 2010, American journal of respiratory and critical care medicine.

[59]  T. Ottenhoff,et al.  Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection , 2010, European journal of immunology.

[60]  H. Vordermeier,et al.  Mycobacterium bovis-BCG Vaccination Induces Specific Pulmonary Transcriptome Biosignatures in Mice , 2010, PloS one.

[61]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[62]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[63]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[64]  R. Adegbola,et al.  Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease , 2009, European journal of immunology.

[65]  G. Kaplan,et al.  Bacillus Calmette-Guérin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles1 , 2008, The Journal of Immunology.

[66]  G. Kaplan,et al.  Bacillus Calmette Guerin Vaccination of Human Newborns Induces a Specific, Functional CD8+ T Cell Response1 , 2006, The Journal of Immunology.

[67]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[68]  A. Crampin,et al.  The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 months. , 2006, Vaccine.

[69]  M. Barreto,et al.  Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial , 2005, The Lancet.

[70]  H. McShane,et al.  Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans , 2004, Nature Medicine.

[71]  M. Barreto,et al.  Rates of adverse reactions to first and second doses of BCG vaccination: results of a large community trial in Brazilian schoolchildren. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[72]  P. E. M. Fine,et al.  Variation in protection by BCG: implications of and for heterologous immunity , 1995, The Lancet.

[73]  C S Berkey,et al.  The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. , 1995, Pediatrics.

[74]  Skipper Seabold,et al.  Statsmodels: Econometric and Statistical Modeling with Python , 2010, SciPy.

[75]  Eric Jones,et al.  SciPy: Open Source Scientific Tools for Python , 2001 .

[76]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .